Circulating tumour cells (CTCs) are heterogenous and contain genetic information from the
tumour of origin. They bear specific intra-and extra-cellular protein markers aiding in their …

The presence of circulating tumor cells (CTCs) in the blood of ovarian cancer patients was
shown to correlate with decreased overall survival, whereby CTCs with epithelial …

Background: Current diagnosis and staging of advanced epithelial ovarian cancer (aEOC)
has important limitations and better biomarkers are needed. We investigate the performance …

OBJECTIVE: The study aims at identifying novel markers for circulating tumor cells (CTCs) in
patients with epithelial ovarian cancer (EOC), and at evaluating their impact on outcome …

Circulating tumor cells (CTC) released into blood from primary cancers and metastases
reflect the current status of tumor genotypes, which are prone to changes. Here, we …

Circulating tumour cells (CTCs) are rare tumour cells found in the circulatory system of
certain cancer patients. The clinical and functional significance of CTCs is still under …

The main focus of the study was to detect circulating tumor cells (CTCs) in ovarian cancer
(OC) patients using a new methodological approach (MetaCell TM) which is based on size …

Simple Summary Circulating tumor cells (CTCs) are rare cells found in the bloodstream of
oncologic patients with a central role in the metastatic spread. In this study, we aim at …

Tumor cells detach from the primary tumor or metastatic sites and enter the peripheral blood,
often causing metastasis. These cells, named Circulating Tumor Cells (CTCs), display the …

Circulating tumor cells (CTCs) are cancer cells discovered in cancer patients' peripheral
blood that successfully escape from the primary tumor site and/or metastases, struggle to …